Fmr LLC Purchases 1,170,202 Shares of Trupanion, Inc. (NASDAQ:TRUP)

FMR LLC boosted its stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 55,963.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,172,293 shares of the financial services provider's stock after acquiring an additional 1,170,202 shares during the quarter. FMR LLC owned approximately 2.77% of Trupanion worth $49,213,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Quest Partners LLC bought a new position in shares of Trupanion in the 3rd quarter valued at about $37,000. GAMMA Investing LLC grew its stake in shares of Trupanion by 70.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider's stock worth $61,000 after acquiring an additional 596 shares in the last quarter. Entropy Technologies LP bought a new position in shares of Trupanion during the 3rd quarter worth approximately $202,000. Mutual of America Capital Management LLC bought a new position in shares of Trupanion during the 3rd quarter worth approximately $210,000. Finally, Headlands Technologies LLC bought a new position in shares of Trupanion during the 2nd quarter worth approximately $162,000.

Wall Street Analysts Forecast Growth

TRUP has been the subject of several research reports. Piper Sandler raised their price target on shares of Trupanion from $45.00 to $57.00 and gave the stock a "neutral" rating in a research note on Thursday, October 31st. Northland Securities raised their target price on shares of Trupanion from $45.00 to $50.00 and gave the company a "market perform" rating in a research note on Thursday, October 31st. Bank of America lifted their price objective on shares of Trupanion from $47.00 to $56.00 and gave the stock a "buy" rating in a research report on Friday, September 20th. Finally, Stifel Nicolaus lifted their price objective on shares of Trupanion from $30.00 to $40.00 and gave the stock a "hold" rating in a research report on Monday, September 23rd. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Trupanion currently has a consensus rating of "Moderate Buy" and an average price target of $44.67.

Trupanion Price Performance

TRUP stock traded up $1.87 during midday trading on Friday, reaching $53.46. The company had a trading volume of 459,460 shares, compared to its average volume of 556,974. The company has a market capitalization of $2.26 billion, a price-to-earnings ratio of -167.06 and a beta of 1.60. The stock has a 50 day moving average price of $51.08 and a 200-day moving average price of $41.11. Trupanion, Inc. has a 1-year low of $19.69 and a 1-year high of $57.90. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.06) by $0.09. The business had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. Trupanion's revenue for the quarter was up 14.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.10) earnings per share. Equities research analysts expect that Trupanion, Inc. will post -0.23 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Murray B. Low sold 2,000 shares of the business's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total transaction of $105,340.00. Following the sale, the director now directly owns 131,513 shares in the company, valued at approximately $6,926,789.71. The trade was a 1.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Fawwad Qureshi sold 622 shares of the business's stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total value of $32,723.42. Following the sale, the chief financial officer now owns 9,867 shares in the company, valued at approximately $519,102.87. This trade represents a 5.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 28,405 shares of company stock valued at $1,512,482. 5.50% of the stock is currently owned by corporate insiders.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.